PD-1 Blockers: Staying Long in the Body and Delayed Toxicity Risks
Masahide Fukudo, Takaaki Sasaki, Yoshinobu Ohsaki
Topics & Concepts
MedicinePembrolizumabNivolumabDiscontinuationInternal medicineAdverse effectMelanomaOncologyLung cancerCancerImmunotherapyCancer researchCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune Responses